New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
GI bleeding up for new users of rivaroxaban

GI bleeding up for new users of rivaroxaban

Rivaroxaban is associated with increased rates of gastrointestinal bleeding (GIB) compared with other direct oral anticoagulants, according to a study published online Oct. 12 in theAnnals of In
Gastroenterology May 29,2024
GI bleeding up for new users of rivaroxaban

GI bleeding up for new users of rivaroxaban

Rivaroxaban is associated with increased rates of gastrointestinal bleeding (GIB) compared with other direct oral anticoagulants, according to a study published online Oct. 12 in theAnnals of In
Gastroenterology May 29,2024
Maddening itch of liver disease comes from a surprising source

Maddening itch of liver disease comes from a surprising source

by Duke University School of NursingExcess lipids produced by liver failure signal an itching sensation directly to the skin cells, through a receptor called TRPV4 and a microRNA. Credit: Wolfgan
Hepatobiliary&Pancreas Surgery May 29,2024
Maddening itch of liver disease comes from a surprising source

Maddening itch of liver disease comes from a surprising source

by Duke University School of NursingExcess lipids produced by liver failure signal an itching sensation directly to the skin cells, through a receptor called TRPV4 and a microRNA. Credit: Wolfgan
Hepatobiliary&Pancreas Surgery May 29,2024
Chronic inflammatory bowel diseases: Predicting the success of biologicals

Chronic inflammatory bowel diseases: Predicting the success of biologicals

by Kiel UniversityThe international team led by Prof. Philip Rosenstiel and Prof. Stefan Schreiber has studied gene expression and DNA methylation in blood samples from CED patients receiving ant
Gastroenterology May 29,2024
Chronic inflammatory bowel diseases: Predicting the success of biologicals

Chronic inflammatory bowel diseases: Predicting the success of biologicals

by Kiel UniversityThe international team led by Prof. Philip Rosenstiel and Prof. Stefan Schreiber has studied gene expression and DNA methylation in blood samples from CED patients receiving ant
Gastroenterology May 29,2024
Clinically active IBD linked to adverse COVID-19 outcomes

Clinically active IBD linked to adverse COVID-19 outcomes

(HealthDay)—Clinically active inflammatory bowel disease (IBD) is associated with adverse COVID-19 outcomes, especially in younger and middle-aged adults, according to a study published online Sept. 2
Gastroenterology May 29,2024
Clinically active IBD linked to adverse COVID-19 outcomes

Clinically active IBD linked to adverse COVID-19 outcomes

(HealthDay)—Clinically active inflammatory bowel disease (IBD) is associated with adverse COVID-19 outcomes, especially in younger and middle-aged adults, according to a study published online Sept. 2
Gastroenterology May 29,2024
Two-organ chip developed to answer fatty liver questions

Two-organ chip developed to answer fatty liver questions

by Kyoto UniversityThe interaction between the small intestine and the liver of patients with non-alcoholic fatty liver disease (NAFLD) has been reproduced on a small chip. Credit: Mindy Takamiya
Hepatobiliary&Pancreas Surgery May 29,2024
Two-organ chip developed to answer fatty liver questions

Two-organ chip developed to answer fatty liver questions

by Kyoto UniversityThe interaction between the small intestine and the liver of patients with non-alcoholic fatty liver disease (NAFLD) has been reproduced on a small chip. Credit: Mindy Takamiya
Hepatobiliary&Pancreas Surgery May 29,2024
Perceived cancer risk from colitis-related dysplasia varies by clinician

Perceived cancer risk from colitis-related dysplasia varies by clinician

(HealthDay)—Perceptions of cancer risk for colitis-associated dysplasia vary widely among clinicians, according to a study published in the January issue of theJournal of Crohn's and Colitis
Gastroenterology May 29,2024
Perceived cancer risk from colitis-related dysplasia varies by clinician

Perceived cancer risk from colitis-related dysplasia varies by clinician

(HealthDay)—Perceptions of cancer risk for colitis-associated dysplasia vary widely among clinicians, according to a study published in the January issue of theJournal of Crohn's and Colitis
Gastroenterology May 29,2024
Fecal transplant plus fibre supplements improve insulin sensitivity in severely obese patients, clinical trial shows

Fecal transplant plus fibre supplements improve insulin sensitivity in severely obese patients, clinical trial shows

by University of AlbertaA clinical trial led by medicine professor Karen Madsen showed that a single oral fecal transplant followed by fibre supplements improved insulin sensitivity in severely o
Gastroenterology May 29,2024
Fecal transplant plus fibre supplements improve insulin sensitivity in severely obese patients, clinical trial shows

Fecal transplant plus fibre supplements improve insulin sensitivity in severely obese patients, clinical trial shows

by University of AlbertaA clinical trial led by medicine professor Karen Madsen showed that a single oral fecal transplant followed by fibre supplements improved insulin sensitivity in severely o
Gastroenterology May 29,2024
Preclinical study finds gut fungi influence neuroimmunity and behavior

Preclinical study finds gut fungi influence neuroimmunity and behavior

by Weill Cornell Medical CollegeFungi in the intestinal mucosa induce immune signals (IL-17 cytokines) that impact the nervous system and animal behavior. Credit: Katarina Liberatore.A specific g
Gastroenterology May 29,2024
Preclinical study finds gut fungi influence neuroimmunity and behavior

Preclinical study finds gut fungi influence neuroimmunity and behavior

by Weill Cornell Medical CollegeFungi in the intestinal mucosa induce immune signals (IL-17 cytokines) that impact the nervous system and animal behavior. Credit: Katarina Liberatore.A specific g
Gastroenterology May 29,2024
Immune therapies against chronic hepatitis B

Immune therapies against chronic hepatitis B

by Ehime UniversityTwo main types of immune therapies have been employed to treat chronic hepatitis B during the last 4 decades. However, it seems that HBV-antigen-specific immune therapy may be safe
Hepatobiliary&Pancreas Surgery May 29,2024
Immune therapies against chronic hepatitis B

Immune therapies against chronic hepatitis B

by Ehime UniversityTwo main types of immune therapies have been employed to treat chronic hepatitis B during the last 4 decades. However, it seems that HBV-antigen-specific immune therapy may be safe
Hepatobiliary&Pancreas Surgery May 29,2024
No immunoglobulin A leads to intestinal inflammation in mice

No immunoglobulin A leads to intestinal inflammation in mice

by Tokyo Medical and Dental UniversityThe small intestine is composed of duodenum, jejunum and ileum (left). IgA deficiency causes distortion of the gut microbiota, especially in the ileum, and inflam
Gastroenterology May 29,2024
No immunoglobulin A leads to intestinal inflammation in mice

No immunoglobulin A leads to intestinal inflammation in mice

by Tokyo Medical and Dental UniversityThe small intestine is composed of duodenum, jejunum and ileum (left). IgA deficiency causes distortion of the gut microbiota, especially in the ileum, and inflam
Gastroenterology May 29,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com